Statera Biopharma Inc (STAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||
| Net Income | -7,223 | -2,387 | -2,523 |
| Depreciation Amortization | 95 | 45 | 2 |
| Accounts receivable | -165 | 188 | -225 |
| Accounts payable and accrued liabilities | 380 | 11 | 170 |
| Other Working Capital | -156 | 156 | 53 |
| Other Operating Activity | 415 | 256 | 2,315 |
| Operating Cash Flow | $-6,654 | $-1,731 | $-208 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 400 | -2,400 | N/A |
| PPE Investments | -188 | -329 | -28 |
| Purchase Sale Intangibles | -177 | -76 | N/A |
| Other Investing Activity | -227 | -76 | 0 |
| Investing Cash Flow | $-14 | $-2,805 | $-28 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 50 | 334 |
| Common Stock Issued | 10,203 | 6,000 | 0 |
| Other Financing Activity | -1,680 | -403 | -13 |
| Financing Cash Flow | $8,523 | $5,647 | $321 |
| Beginning Cash Position | 1,207 | 95 | 10 |
| End Cash Position | 3,062 | 1,207 | 95 |
| Net Cash Flow | $1,856 | $1,112 | $85 |
| Free Cash Flow | |||
| Operating Cash Flow | -6,654 | -1,731 | -208 |
| Capital Expenditure | -188 | -329 | -28 |
| Free Cash Flow | -6,841 | -2,059 | -236 |